Skip to content
Psilocybin Therapy in States Helps Legalize Magic Mushrooms in the US

The Biden administration seeks to explore emerging research on psilocybin to treat a variety of mental illnesses as states across the country begin to decriminalize and legalize substances for medical purposes.

The administration expects the FDA to approve both MDMA and psilocybin as treatments for PTSD and depression within the next two years, and is “exploring the prospect of establishing a federal task force” to monitor the drugs, according to a report. letter from Miriam Delphin-Rittmon, the assistant secretary for mental health and addiction, sent to Rep. Madeleine Dean, D-Penn.

USA Today

Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.